Michael Gelband’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$172M Buy
+1,991,602
New +$176M 0.91% 18
2025
Q3
– Sell
-44,754
Closed -$3.9M – 1831
2025
Q2
$3.9M Sell
44,754
-476,538
-91% -$40.4M 0.03% 497
2025
Q1
$46.8M Buy
521,292
+53,925
+12% +$4.83M 0.46% 29
2024
Q4
$37.3M Sell
467,367
-441,181
-49% -$38.2M 0.26% 57
2024
Q3
$81.8M Buy
908,548
+643,034
+242% +$54.1M 0.5% 26
2024
Q2
$20.9M Buy
+265,514
New +$21.8M 0.14% 125
2024
Q1
– Sell
-388,062
Closed -$32M – 1780
2023
Q4
$32M Buy
388,062
+223,424
+136% +$17M 0.21% 64
2023
Q3
$12.9M Buy
164,638
+118,717
+259% +$9.9M 0.12% 176
2023
Q2
$4.05M Sell
45,921
-45,420
-50% -$3.91M 0.03% 530
2023
Q1
$7.36M Sell
91,341
-96,729
-51% -$7.88M 0.06% 385
2022
Q4
$14.6M Buy
188,070
+123,864
+193% +$10M 0.21% 108
2022
Q3
$5.18M Buy
+64,206
New +$5.77M 0.07% 387
2022
Q1
– Sell
-157,937
Closed -$16.3M – 2480
2021
Q4
$16.3M Buy
157,937
+90,461
+134% +$10.5M 0.17% 105
2021
Q3
$8.46M Sell
67,476
-15,576
-19% -$2.02M 0.11% 232
2021
Q2
$10.3M Buy
83,052
+6,642
+9% +$834K 0.11% 143
2021
Q1
$9.03M Sell
76,410
-99,341
-57% -$11.6M 0.13% 141
2020
Q4
$20.6M Buy
175,751
+123,956
+239% +$13.6M 0.2% 48
2020
Q3
$5.38M Sell
51,795
-11,525
-18% -$1.16M 0.11% 164
2020
Q2
$5.81M Buy
63,320
+5,507
+10% +$528K 0.15% 125
2020
Q1
$5.21M Buy
57,813
+24,357
+73% +$2.59M 0.29% 57
2019
Q4
$3.8M Buy
+33,456
New +$3.67M 0.07% 205
2019
Q2
– Sell
-8,592
Closed -$783K – 1246
2019
Q1
$783K Buy
+8,592
New +$769K 0.06% 235

Other funds holding MDT

Michael Gelband's MDT Position: Q3 2026 in Review

Michael Gelband opened a new position in Medtronic (MDT) in Q3 2026: 1,991,602 shares worth $172M. The stake represents 0.91% of the portfolio and ranks #18 among its holdings. This is a return to the name: Michael Gelband previously reported a position in MDT as recently as Q2 2025.

Michael Gelband first reported a position in MDT in Q1 2019 and has held it in 22 quarters since. 2,206 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Michael Gelband held 1,991,602 shares of Medtronic worth $172M as of Q3 2026.
  • Medtronic was a new Michael Gelband position in Q3 2026.
  • Medtronic made up 0.91% of Michael Gelband's portfolio in Q3 2026, its #18 holding.
  • Michael Gelband first reported a position in Medtronic in Q1 2019 and has held it in 22 quarters since.
  • 2,206 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.